Company intelligence / Profile preview

Baebies

Durham, North Carolina, United Statesbaebies.com ↗

Ownership: Private
Employees: ~80
Development stage: Commercial

Overview

Baebies has delivered over 22 million tests globally. Its FINDER platform’s G6PD chemistry test is FDA-cleared and CE-marked. The Anti-Factor Xa coagulation test received FDA Breakthrough Device Designation in April 2025. Additional molecular and immunoassay tests are advancing through clinical studies[1][2][5].

Therapeutic areas: Infectious DiseasesHematology
Modalities: DeviceMolecular diagnosticsImmunoassayChemistry assayCoagulation assay
Industry: Molecular Diagnostics

Partnerships

Labsystems Diagnostics (global distribution partnership for newborn screening)[3]NIH-funded collaborations[2][5]BARDA/RADX support for innovation[2]

Beyond the preview

Go deeper on Baebies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Baebies.

Explore the full profile